GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Cyclically Adjusted PB Ratio

Alkem Laboratories (NSE:ALKEM) Cyclically Adjusted PB Ratio : (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Alkem Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alkem Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Cyclically Adjusted PB Ratio Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 6.28 -

Competitive Comparison of Alkem Laboratories's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Cyclically Adjusted PB Ratio falls into.



Alkem Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alkem Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Alkem Laboratories's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/152.9243*152.9243
=0.000

Current CPI (Dec. 2023) = 152.9243.

Alkem Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201203 159.357 76.889 316.946
201303 198.524 85.687 354.303
201403 222.043 91.425 371.406
201412 0.000 96.780 0.000
201503 260.835 97.163 410.527
201506 0.000 99.841 0.000
201509 0.000 101.753 0.000
201512 0.000 102.901 0.000
201603 308.783 102.518 460.605
201606 0.000 105.961 0.000
201609 350.767 105.961 506.231
201612 0.000 105.196 0.000
201703 373.658 105.196 543.190
201706 0.000 107.109 0.000
201709 395.573 109.021 554.870
201712 0.000 109.404 0.000
201803 406.789 109.786 566.627
201806 0.000 111.317 0.000
201809 437.000 115.142 580.396
201812 0.000 115.142 0.000
201903 454.927 118.202 588.563
201906 0.000 120.880 0.000
201909 491.390 123.175 610.071
201912 0.000 126.235 0.000
202003 515.257 124.705 631.853
202006 0.000 127.000 0.000
202009 585.171 130.118 687.737
202012 0.000 130.889 0.000
202103 616.964 131.771 716.008
202106 0.000 134.084 0.000
202109 697.015 135.847 784.637
202112 0.000 138.161 0.000
202203 722.444 138.822 795.835
202206 0.000 142.347 0.000
202209 764.580 144.661 808.254
202212 0.000 145.763 0.000
202303 756.517 146.865 787.731
202306 0.000 150.280 0.000
202309 823.192 151.492 830.975
202312 0.000 152.924 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alkem Laboratories  (NSE:ALKEM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alkem Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines